A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Single Dose Regimen of Live Attenuated Oral Cholera Vaccine (CholeraGarde) in HIV-Seropositive Adults in Thailand

Trial Profile

A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Single Dose Regimen of Live Attenuated Oral Cholera Vaccine (CholeraGarde) in HIV-Seropositive Adults in Thailand

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Feb 2016

At a glance

  • Drugs Cholera vaccine live attenuated (Primary)
  • Indications Cholera
  • Focus Adverse reactions
  • Most Recent Events

    • 29 Mar 2012 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
    • 29 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 May 2011 Planned end date changed from 1 Jan 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top